2,7-Disubstituted-pyrrolotriazine kinase inhibitors with an unusually high degree of reactive metabolite formation.

Wells-Knecht, Kevin J; Ott, Gregory R; Cheng, Mangeng; Wells, Gregory J; Breslin, Henry J; Gingrich, Diane E; Weinberg, Linda; Mesaros, Eugen F; Huang, Zeqi; Yazdanian, Mehran; Ator, Mark A; Aimone, Lisa D; Zeigler, Kelli; Dorsey, Bruce D.
Chem Res Toxicol; 24(11): 1994-2003, 2011 Nov 21.
Artigo em Inglês | MEDLINE | ID: mdl-22023349